Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,126 Jan 1 – Oct 9, 2026
- Disclosed funding
- $199.4B 1760 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| MT Mirador TherapeuticsCompany profile Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases | $250M | Series B | Biotech | United States | Investors | |
| AA Allos AICompany profile Causal AI and pharmaceutical development services for reformulating complex drugs and directing laboratory studies. Causal AI and pharmaceutical development services for reformulating complex drugs and directing laboratory studies. | $5M | Seed | AI | United States | Investors | |
| TB Trailhead BiosystemsCompany profile Develops human cells with defined molecular and functional properties for drug discovery and regenerative medicine Develops human cells with defined molecular and functional properties for drug discovery and regenerative medicine | $20M | Growth | Biotech | United States | Investors | |
| CA Cast AICompany profile Provides automation platform for operating cloud-native and AI workloads at scale Provides automation platform for operating cloud-native and AI workloads at scale | Undisclosed | StrategicUndisclosed | Developer tools | United States | Investors | |
| A AccelsiusCompany profile Two-phase liquid cooling for data centres running dense AI and high-performance computing workloads. Two-phase liquid cooling for data centres running dense AI and high-performance computing workloads. | $65M | Series B | Hardware | United States | Investors | |
| JT Develops regenerative biologics to restore tissue function | $33.5M | Series B | Biotech | United States | Investors | |
| C CardamomCompany profile Provides health IT professional services for data, analytics, AI, and applications Provides health IT professional services for data, analytics, AI, and applications | Undisclosed | MinorityUndisclosed | Healthtech | United States | Investors | |
| AH Avalon Healthcare SolutionsCompany profile Avalon Healthcare Solutions combines laboratory science and data to provide laboratory insights to health plans. Avalon Healthcare Solutions combines laboratory science and data to provide laboratory insights to health plans. | Undisclosed | Undisclosed | Healthtech | United States | Investors | |
| IM Inquis MedicalCompany profile Develops mechanical thrombectomy systems for venous thromboembolic disease Develops mechanical thrombectomy systems for venous thromboembolic disease | $75M | Series CSeries C+ | Healthtech | United States | Investors Undisclosed | |
| M Provides software-based security for payments, identity, and digital assets | $10M | Undisclosed | Fintech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
125rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
94rounds18led - 3General Catalyst
Minerva Humanoids, Melius
65rounds6led - 4Alumni Ventures
Savvy Wealth, Mona, American Supercritical
55rounds0led - 5Khosla Ventures
Arena, Vinci, Conway Research
54rounds5led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.